Axogen, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Axogen, Inc. (AXGN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 40.71 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-06
- Axogen, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 40.71M shares, a 2.54% increase year-over-year.
- Axogen, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 40.25M shares, a 1.93% increase year-over-year.
- Axogen, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 40.09M shares, a 1.91% increase year-over-year.
- Axogen, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 39.82M shares, a 1.66% increase year-over-year.
- Axogen, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 39.97M shares, a 1.87% increase from fiscal 2019.
- Axogen, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 39.23M shares, a 5.68% increase from fiscal 2018.
- Axogen, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 37.13M shares, a 111315.54% increase from fiscal 2017.
- Axogen, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 33.32K shares, a 8.54% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2021-03-31 | 40.71M shares 10-Q · filed 2021-05-06 | 40.48M shares derived: average of 2 quarters · filed 2021-05-06 | 40.35M shares derived: average of 3 quarters · filed 2021-05-06 | 40.22M shares derived: average of 4 quarters · filed 2021-05-06 | |
| 2020-12-31 | 40.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 40.17M shares derived: average of 2 quarters · filed 2021-03-01 | 40.06M shares derived: average of 3 quarters · filed 2021-03-01 | 39.97M shares 10-K · filed 2021-03-01 | |
| 2020-09-30 | 40.09M shares 10-Q · filed 2020-10-30 | 39.96M shares derived: average of 2 quarters · filed 2020-10-30 | 39.87M shares 10-Q · filed 2020-10-30 | 39.78M shares derived: average of 4 quarters · filed 2021-05-06 | |
| 2020-06-30 | 39.82M shares 10-Q · filed 2020-08-07 | 39.76M shares 10-Q · filed 2020-08-07 | 39.67M shares derived: average of 3 quarters · filed 2021-05-06 | 39.59M shares derived: average of 4 quarters · filed 2021-05-06 | |
| 2020-03-31 | 39.70M shares 10-Q · filed 2021-05-06 | 39.59M shares derived: average of 2 quarters · filed 2021-05-06 | 39.51M shares derived: average of 3 quarters · filed 2021-05-06 | 39.42M shares derived: average of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | 39.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 39.41M shares derived: average of 2 quarters · filed 2021-03-01 | 39.33M shares derived: average of 3 quarters · filed 2021-03-01 | 39.23M shares 10-K · filed 2021-03-01 | 39.23K shares 10-K · filed 2020-02-24 |
| 2019-09-30 | 39.34M shares 10-Q · filed 2020-10-30 | 39.26M shares derived: average of 2 quarters · filed 2020-10-30 | 39.15M shares 10-Q · filed 2020-10-30 | 39.05M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | 39.17M shares 10-Q · filed 2020-08-07 | 39.06M shares 10-Q · filed 2020-08-07 | 38.96M shares derived: average of 3 quarters · filed 2021-03-01 | 38.84M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | 38.93M shares 10-Q · filed 2020-05-06 | 38.85M shares derived: average of 2 quarters · filed 2021-03-01 | 38.73M shares derived: average of 3 quarters · filed 2021-03-01 | 38.22M shares derived: average of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | 38.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 38.63M shares derived: average of 2 quarters · filed 2021-03-01 | 37.98M shares derived: average of 3 quarters · filed 2021-03-01 | 37.13M shares 10-K · filed 2021-03-01 | 37.13K shares 10-K · filed 2019-02-26 |
| 2018-09-30 | 38.50M shares 10-Q · filed 2019-11-06 | 37.59M shares derived: average of 2 quarters · filed 2019-11-06 | 36.58M shares 10-Q · filed 2019-11-06 | 2.60M shares derived: average of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | 36.68M shares 10-Q · filed 2019-08-06 | 35.61M shares 10-Q · filed 2019-08-06 | -9.37M shares derived: average of 3 quarters · filed 2020-02-24 | 1.29M shares derived: average of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | 34.52M shares 10-Q · filed 2019-05-08 | -32.39M shares derived: average of 2 quarters · filed 2020-02-24 | -10.50M shares derived: average of 3 quarters · filed 2020-02-24 | 406.28K shares derived: average of 4 quarters · filed 2020-02-24 | |
| 2017-12-31 | -99.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -33.01M shares derived: average of 2 quarters · filed 2020-02-24 | -10.97M shares derived: average of 3 quarters · filed 2020-02-24 | 33.32K shares 10-K · filed 2020-02-24 | 33.32M shares 10-K · filed 2018-02-28 |
| 2017-09-30 | 33.29M shares 10-Q · filed 2018-10-29 | 33.21M shares derived: average of 2 quarters · filed 2018-10-29 | 33.15M shares 10-Q · filed 2018-10-29 | 2.33M shares derived: average of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | 33.12M shares 10-Q · filed 2018-08-01 | 33.08M shares 10-Q · filed 2018-08-01 | -7.98M shares derived: average of 3 quarters · filed 2019-02-26 | 1.55M shares derived: average of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | 33.03M shares 10-Q · filed 2018-04-30 | -28.54M shares derived: average of 2 quarters · filed 2019-02-26 | -8.98M shares derived: average of 3 quarters · filed 2019-02-26 | 788.58K shares derived: average of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | -90.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -29.98M shares derived: average of 2 quarters · filed 2019-02-26 | -9.96M shares derived: average of 3 quarters · filed 2019-02-26 | 30.70K shares 10-K · filed 2019-02-26 | 30.70M shares 10-K · filed 2017-03-01 |
| 2016-09-30 | 30.15M shares 10-Q · filed 2017-11-01 | 30.12M shares derived: average of 2 quarters · filed 2017-11-01 | 30.08M shares 10-Q · filed 2017-11-01 | 30.05M shares derived: average of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | 30.08M shares 10-Q · filed 2017-08-02 | 30.04M shares 10-Q · filed 2017-08-02 | 30.01M shares derived: average of 3 quarters · filed 2018-02-28 | 29.22M shares derived: average of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | 29.99M shares 10-Q · filed 2017-05-04 | 29.98M shares derived: average of 2 quarters · filed 2018-02-28 | 28.93M shares derived: average of 3 quarters · filed 2018-02-28 | 27.93M shares derived: average of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | 29.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | 28.40M shares derived: average of 2 quarters · filed 2018-02-28 | 27.25M shares derived: average of 3 quarters · filed 2018-02-28 | 26.08M shares 10-K · filed 2018-02-28 | |
| 2015-09-30 | 26.84M shares 10-Q · filed 2016-11-02 | 25.88M shares derived: average of 2 quarters · filed 2016-11-02 | 24.78M shares 10-Q · filed 2016-11-02 | 23.22M shares derived: average of 4 quarters · filed 2016-11-02 | |
| 2015-06-30 | 24.93M shares 10-Q · filed 2016-08-03 | 23.73M shares 10-Q · filed 2016-08-03 | 22.01M shares derived: average of 3 quarters · filed 2016-08-03 | 20.87M shares derived: average of 4 quarters · filed 2016-08-03 | |
| 2015-03-31 | 22.52M shares 10-Q · filed 2016-05-04 | 20.55M shares derived: average of 2 quarters · filed 2016-05-04 | 19.52M shares derived: average of 3 quarters · filed 2016-05-04 | 19.00M shares derived: average of 4 quarters · filed 2016-05-04 | |
| 2014-12-31 | 18.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 18.02M shares derived: average of 2 quarters · filed 2016-02-29 | 17.83M shares derived: average of 3 quarters · filed 2016-02-29 | 17.72M shares 10-K · filed 2016-02-29 | |
| 2014-09-30 | 17.47M shares 10-Q · filed 2015-11-05 | 17.46M shares derived: average of 2 quarters · filed 2015-11-05 | 17.44M shares 10-Q · filed 2015-11-05 | 17.42M shares derived: average of 4 quarters · filed 2015-11-05 | |
| 2014-06-30 | 17.46M shares 10-Q · filed 2015-08-06 | 17.42M shares 10-Q · filed 2015-08-06 | 17.41M shares derived: average of 3 quarters · filed 2015-08-06 | 16.64M shares derived: average of 4 quarters · filed 2015-08-06 | |
| 2014-03-31 | 17.38M shares 10-Q · filed 2015-05-05 | 17.38M shares derived: average of 2 quarters · filed 2015-05-05 | 16.36M shares derived: average of 3 quarters · filed 2015-05-05 | 15.06M shares derived: average of 4 quarters · filed 2015-05-05 | |
| 2013-12-31 | 17.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | 15.85M shares derived: average of 2 quarters · filed 2015-03-05 | 14.28M shares derived: average of 3 quarters · filed 2015-03-05 | 13.50M shares 10-K · filed 2015-03-05 | |
| 2013-09-30 | 14.32M shares 10-Q · filed 2014-11-13 | 12.73M shares derived: average of 2 quarters · filed 2014-11-13 | 12.21M shares 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | 11.14M shares 10-Q · filed 2014-08-04 | 11.13M shares 10-Q · filed 2014-08-04 | |||
| 2013-03-31 | 11.12M shares 10-Q · filed 2014-04-30 | ||||
| 2012-12-31 | 11.09M shares 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |